A study by Kandasamy et al. showed that KRAS mutant cancer cells upregulated the amino acid transporters LAT1 (SLC7A5), SNAT2 (SLC38A2), and ASCT2 (SLC1A5) [210]. This evidence concerns the gene SLC38A2 and cancer.